BRCA1/2 Germline Mutations in Jewish Patients With Uterine Serous Carcinoma
Authors:
- Ilan BruchimIBIlan Bruchim
- Keren AmichayKAKeren Amichay
- Dvora KidronDKDvora Kidron
- Zohar AttiasZAZohar Attias
- Tal Biron-ShentalTBTal Biron-Shental
- Liat DruckerLDLiat Drucker
- Eitan FriedmanEFEitan Friedman
- Haim WernerHWHaim Werner
- Ami FishmanAFAmi Fishman
- 1 October 2010
- journal article
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 20 (7) , 1148-1153
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- High incidence of BRCA1–2 germline mutations, previous breast cancer and familial cancer history in Jewish patients with uterine serous papillary carcinomaEuropean Journal of Surgical Oncology, 2006
- Cancer risks in BRCA2 families: estimates for sites other than breast and ovaryJournal of Medical Genetics, 2005
- Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2Science, 2003
- Is Uterine Papillary Serous Adenocarcinoma a Manifestation of the Hereditary Breast–Ovarian Cancer Syndrome?Gynecologic Oncology, 2000
- Prevalence and Penetrance of BRCA1 and BRCA2 Gene Mutations in Unselected Ashkenazi Jewish Women With Breast CancerJNCI: Journal of the National Cancer Institute, 1999
- The Risk of Cancer Associated with Specific Mutations ofBRCA1andBRCA2among Ashkenazi JewsNew England Journal of Medicine, 1997
- High Frequency of BRCA1 185delAG Mutation in Ovarian Cancer in Israel1996
- Death Rate and Recurrence Pattern among 841 Clinical Stage I Endometrial Cancer Patients with Special Reference to Uterine Papillary Serous CarcinomaGynecologic Oncology, 1993
- Papillary carcinomas of the endometriumGynecologic Oncology, 1990
- Uterine papillary serous carcinomaAmerican Journal of Surgical Pathology, 1982